These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24740430)

  • 1. PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
    Brown D; Tamas A; Reglodi D; Tizabi Y
    Neurotox Res; 2014 Oct; 26(3):230-9. PubMed ID: 24740430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.
    Brown D; Tamas A; Reglödi D; Tizabi Y
    J Mol Neurosci; 2013 Jul; 50(3):600-7. PubMed ID: 23625270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity.
    Manavalan S; Getachew B; Manaye KF; Khundmiri SJ; Csoka AB; McKinley R; Tamas A; Reglodi D; Tizabi Y
    Neurotox Res; 2017 Jul; 32(1):8-13. PubMed ID: 28342135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model.
    Lamine A; Létourneau M; Doan ND; Maucotel J; Couvineau A; Vaudry H; Chatenet D; Vaudry D; Fournier A
    Neuropharmacology; 2016 Sep; 108():440-50. PubMed ID: 26006268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease.
    Getachew B; Csoka AB; Bhatti A; Copeland RL; Tizabi Y
    Neurotox Res; 2020 Oct; 38(3):596-602. PubMed ID: 32572814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of PACAP against paraquat-induced oxidative stress in the Drosophila central nervous system.
    Hajji K; Mteyrek A; Sun J; Cassar M; Mezghani S; Leprince J; Vaudry D; Masmoudi-Kouki O; Birman S
    Hum Mol Genet; 2019 Jun; 28(11):1905-1918. PubMed ID: 30715303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress.
    Yang S; Yang J; Yang Z; Chen P; Fraser A; Zhang W; Pang H; Gao X; Wilson B; Hong JS; Block ML
    J Pharmacol Exp Ther; 2006 Nov; 319(2):595-603. PubMed ID: 16891616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP+-induced alteration of translational control in Neuro-2a neuroblastoma cells.
    Deguil J; Jailloux D; Page G; Fauconneau B; Houeto JL; Philippe M; Muller JM; Pain S
    J Neurosci Res; 2007 Jul; 85(9):2017-25. PubMed ID: 17492795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease.
    Lamine-Ajili A; Fahmy AM; Létourneau M; Chatenet D; Labonté P; Vaudry D; Fournier A
    Biochim Biophys Acta; 2016 Apr; 1862(4):688-695. PubMed ID: 26769362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic actions of PACAP-38 and LIF on human neuroblastoma SH-SY5Y cells.
    Monaghan TK; Pou C; MacKenzie CJ; Plevin R; Lutz EM
    J Mol Neurosci; 2008 Nov; 36(1-3):45-56. PubMed ID: 18506635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression.
    Delgado M
    J Biol Chem; 2003 Jul; 278(30):27620-9. PubMed ID: 12754213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.
    Hammack SE; Cheung J; Rhodes KM; Schutz KC; Falls WA; Braas KM; May V
    Psychoneuroendocrinology; 2009 Jul; 34(6):833-43. PubMed ID: 19181454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.
    Delgado M; Ganea D
    J Biol Chem; 2001 Jan; 276(1):369-80. PubMed ID: 11029467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K; Connell TD; Higgins D
    J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropeptide PACAP promotes the alpha-secretase pathway for processing the Alzheimer amyloid precursor protein.
    Kojro E; Postina R; Buro C; Meiringer C; Gehrig-Burger K; Fahrenholz F
    FASEB J; 2006 Mar; 20(3):512-4. PubMed ID: 16401644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis.
    Masmoudi-Kouki O; Douiri S; Hamdi Y; Kaddour H; Bahdoudi S; Vaudry D; Basille M; Leprince J; Fournier A; Vaudry H; Tonon MC; Amri M
    J Neurochem; 2011 May; 117(3):403-11. PubMed ID: 21244427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival.
    May V; Lutz E; MacKenzie C; Schutz KC; Dozark K; Braas KM
    J Biol Chem; 2010 Mar; 285(13):9749-9761. PubMed ID: 20093365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizic Acid Alleviates 6-Hydroxydopamine and Corticosterone-Induced Neurotoxicity in SH-SY5Y Cells Through Modulating Autophagy.
    Yang G; Li J; Cai Y; Yang Z; Li R; Fu W
    Neurochem Res; 2018 Oct; 43(10):1914-1926. PubMed ID: 30206804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.